Pharmacology of modern ACE inhibitors: moexipril example
ACE inhibitors are widely used in the treatment of arterial hypertension, chronic heart failure, and other cardiovascular pathology. The article is devoted to ACE pharmacology and their optimal use in clinical practice.
| Published in: | Кардиоваскулярная терапия и профилактика |
|---|---|
| Main Authors: | D. P. Khloponin, Yu. N. Krotova, I. V. Ivanov |
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-10-01
|
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1368 |
Similar Items
Moexipril and arterial hypertension treatment in postmenopausal women
by: E. F. Litvinovich
Published: (2006-04-01)
by: E. F. Litvinovich
Published: (2006-04-01)
Moexipril in postmenopausal women with arterial hypertension
by: M. G. Glezer, et al.
Published: (2005-02-01)
by: M. G. Glezer, et al.
Published: (2005-02-01)
Moexipril effects on lung function in patients with arterial hypertension and chronic obstructive pulmonary disease
by: N. V. Ivanova, et al.
Published: (2006-02-01)
by: N. V. Ivanova, et al.
Published: (2006-02-01)
ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)
Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
Use of ACE-inhibitors in Serbia in 2009 and 2010
by: Perić Dajana M., et al.
Published: (2014-01-01)
by: Perić Dajana M., et al.
Published: (2014-01-01)
PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE
by: V. V. Yakusevich, et al.
Published: (2015-12-01)
by: V. V. Yakusevich, et al.
Published: (2015-12-01)
ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)
by: Y. A. Karpov
Published: (2015-12-01)
Crystal structure of [(2S)-1-[(3S)-3-carboxy-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl]-1-oxopropan-2-yl][(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]azanium chloride acetonitrile monosolvate
by: Ai-zhen Li, et al.
Published: (2014-10-01)
by: Ai-zhen Li, et al.
Published: (2014-10-01)
New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)
by: D. V. Nebieridze, et al.
Published: (2010-10-01)
Cough Syncope due to ACE Inhibitor
by: Filiz Koc, et al.
Published: (2015-09-01)
by: Filiz Koc, et al.
Published: (2015-09-01)
ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)
by: V. I. Makolkin
Published: (2005-10-01)
ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)
ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)
by: V. I. Podzolkov, et al.
Published: (2016-01-01)
ACE inhibitors as a risk factor for hypoglycemia
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-12-01)
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-12-01)
Peripheral artery disease: potential role of ACE-inhibitor therapy
by: Giuseppe Coppola, et al.
Published: (2008-12-01)
by: Giuseppe Coppola, et al.
Published: (2008-12-01)
Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
by: Yu. M. Lopatin
Published: (2006-06-01)
by: Yu. M. Lopatin
Published: (2006-06-01)
ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01)
by: M. P. Metrova, et al.
Published: (2016-01-01)
ACE inhibitors and their interaction with systems and molecules involved in metabolism
by: Diana L. Silva-Velasco, et al.
Published: (2024-01-01)
by: Diana L. Silva-Velasco, et al.
Published: (2024-01-01)
Conceptual approaches to cerebral blood flow correction in postmenopausal women with arterial hypertension
by: V. V. Yakusevich, et al.
Published: (2005-04-01)
by: V. V. Yakusevich, et al.
Published: (2005-04-01)
Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)
by: Lima Dênis Pires de
Published: (1999-01-01)
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)
by: E. M. Khurs, et al.
Published: (2016-01-01)
Alu insertion/deletion of ACE gene polymorphism might not affect significantly the serum bradykinin level in hypertensive patients taking ACE inhibitors
by: Widodo, et al.
Published: (2017-04-01)
by: Widodo, et al.
Published: (2017-04-01)
ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)
ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)
ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)
by: Yu. M. Lopatin
Published: (2006-04-01)
Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
by: M. V. Leonova
Published: (1970-01-01)
by: M. V. Leonova
Published: (1970-01-01)
Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)
by: G. A. Baryshnikova
Published: (2007-12-01)
ACE inhibitor cilazapril: its place in cardiovascular diseases treatment
by: G. A. Baryshnikova
Published: (2005-08-01)
by: G. A. Baryshnikova
Published: (2005-08-01)
ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)
by: David S. Weisman, et al.
Published: (2020-01-01)
Pharmacogenomic biomarkers of ACE inhibitor–induced cough in a multi-ethnic UAE cohort
by: Sahar M. Altoum, et al.
Published: (2025-09-01)
by: Sahar M. Altoum, et al.
Published: (2025-09-01)
Review: Investigation of the electrochemical properties of beta blockers and ACE inhibitors by cyclic voltammetry
by: Edhem Hasković, et al.
Published: (2020-06-01)
by: Edhem Hasković, et al.
Published: (2020-06-01)
In-silico study of the Effectiveness of Allium sativum L. extract as an Angiotensin-Converting Enzyme (ACE) Inhibitor in Hypertension
by: Agus Limanto, et al.
Published: (2023-09-01)
by: Agus Limanto, et al.
Published: (2023-09-01)
COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)
Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)
Investigation of the Mechanism and Effect of Enalapril, Angiotensin-Converting Enzyme (ACE) Inhibitor, on Proliferation, Apoptosis, and Migration in Colorectal Cancer Cells
by: Asma Mostafapour, et al.
Published: (2020-08-01)
by: Asma Mostafapour, et al.
Published: (2020-08-01)
Age Dependendent Efficacy of Ace Inhibitors Among Chinese Cardiovascular Patients During Hospitalization Phase
by: Tabish Hussain
Published: (2011-01-01)
by: Tabish Hussain
Published: (2011-01-01)
ACE inhibitor fosinopril in the treatment of hypertension: potential benefits
by: AO Konradi
Published: (2014-12-01)
by: AO Konradi
Published: (2014-12-01)
Fatal angioedema induced by angiotensin conversion enzyme (ACE) inhibitors
by: Marianne Tiemensma, et al.
Published: (2010-06-01)
by: Marianne Tiemensma, et al.
Published: (2010-06-01)
Similar Items
-
Moexipril and arterial hypertension treatment in postmenopausal women
by: E. F. Litvinovich
Published: (2006-04-01) -
Moexipril in postmenopausal women with arterial hypertension
by: M. G. Glezer, et al.
Published: (2005-02-01) -
Moexipril effects on lung function in patients with arterial hypertension and chronic obstructive pulmonary disease
by: N. V. Ivanova, et al.
Published: (2006-02-01) -
ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01) -
Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)
